Please provide your email address to receive an email when new articles are posted on . On May 11, Icelandic-based drug developer Alvotech filed a lawsuit against AbbVie seeking to undo what it ...
Alberta, Canada becomes the latest province to begin switching patients from originator adalimumab (Humira) to biosimilar versions as part of its Biosimilars Initiative. Alberta, Canada has expanded ...
A few days ago, I published an AbbVie (ABBV) article titled "AbbVie: The Humira Situation Remains Scary". In that article, I covered the main implications (for AbbVie) of Humira's impending (2023) ...
Biologic medicines—drugs with complex molecules developed in living cells—have saved lives and improved the quality of life ...
About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease in which the immune system attacks healthy cells, typically around the joints, causing swelling and deformity. Generally ...
LONDON, March 15 (Reuters) - Abbott Laboratories' drug Humira and Enbrel, from Pfizer and Amgen , should be the first choices for treating patients with psoriatic arthritis, Britain's ...
AbbVie and its longtime blockbuster arthritis drug Humira are now front and center in the Outcome Health trial. Outcome Health was a high-flying Chicago company that made headlines when it raised $488 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback